Yes, principles of catalysis are fundamental in the design of enzyme inhibitors like trimethoprim. By understanding the catalytic mechanism and the structure of the enzyme's active site, researchers can design molecules that specifically bind to and inhibit the enzyme. Modern techniques such as enzyme kinetics and molecular docking are used to study how potential inhibitors interact with their target enzymes, leading to the development of more effective and selective drugs.
